About: Implications of SARS-CoV-2 Infection and COVID-19 Crisis on Clinical Cancer Care: Report of the University Cancer Center Hamburg

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Implications of SARS-CoV-2 Infection and COVID-19 Crisis on Clinical Cancer Care: Report of the University Cancer Center Hamburg Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	Implications of SARS-CoV-2 Infection and COVID-19 Crisis on Clinical Cancer Care: Report of the University Cancer Center Hamburg
Creator	Block, Andreas Bokemeyer, Carsten Fiedler, Walter Knobloch, Johannes Morgner-Miehlke, Andrea Petersen, Cordula Schafhausen, Philippe Weisel, Katja Oncol, Res Treat,
source	Medline; PMC
abstract	With the outbreak of the COVID-19 pandemia, routine clinical work was immediately, deeply, and sustainably impacted in Germany and worldwide. The infrastructure of almost all hospitals is currently redirected to provide a maximum of intensive care resources, including the necessary staff. In parallel, routine as well as emergency clinical care for all patients in need has to be secured. This challenge becomes particularly evident in cancer care. In order to maintain adequate oncological care at all levels of provision and to conduct especially curative and intensive treatments with a maximum of safety, continuous adaption of the oncology care system has to be ensured. Intensive communication with colleagues and patients is needed as is consequent expert networking and continuous reflection of the own developed strategies. In parallel, it is of high importance to actively avoid cessation of innovation in order not to endanger the continuous improvement in prognosis of cancer patients. This includes sustained conduction of clinical trials as well as ongoing translational research. Here, we describe measures taken at the University Cancer Center Hamburg (UCCH) − a recognized comprehensive oncology center of excellence − during the COVID-19 crisis. We aim to provide support and potential perspectives to generate a discussion basis on how to maintain high-end cancer care during such a crisis and how to conduct patients safely into the future.
has issue date	2020-05-07(xsd:dateTime)
bibo:doi	10.1159/000508272
bibo:pmid	32380501
has license	no-cc
sha1sum (hex)	00eaa28403c40a1892c493a5ca2df4ac1e6896f8
schema:url	https://doi.org/10.1159/000508272
resource representing a document's title	Implications of SARS-CoV-2 Infection and COVID-19 Crisis on Clinical Cancer Care: Report of the University Cancer Center Hamburg
has PubMed Central identifier	PMC7251567
has PubMed identifier	32380501
schema:publication	Oncol Res Treat
resource representing a document's body	covid:00eaa28403c40a1892c493a5ca2df4ac1e6896f8#body_text
is schema:about of	named entity 'COVID-19' named entity 'Cancer' named entity 'continuous improvement' named entity 'continuous' named entity 'curative' named entity 'evident' named entity 'oncology' named entity 'Cancer Care' named entity 'SARS-CoV-2' named entity 'adaption' named entity 'safety' named entity 'cancer care' named entity 'worldwide' named entity 'avoid' named entity 'system' named entity 'prognosis' named entity 'provision' named entity 'cancer care' named entity 'reflection' named entity 'COVID-19' named entity 'continuous improvement' named entity 'clinical care' named entity 'Hamburg' named entity 'clinical trials' named entity 'Cancer Care' named entity 'Cancer Care' named entity 'Infection' named entity 'communication' named entity 'SARS-CoV-2' named entity 'tumor' named entity 'outpatient care' named entity 'Lübeck' named entity 'Hamburg' named entity 'prostate cancer' named entity 'COVID' named entity 'Adjuvant' named entity 'UKE' named entity 'aplasia' named entity 'clinical care' named entity 'Interdisciplinary' named entity 'risk of transmission' named entity 'COVID' named entity 'cancer care' named entity 'UCCH' named entity 'cancer center' named entity 'palliative care' named entity 'COVID-19' named entity 'SARS-CoV-2' named entity 'ICU' named entity 'anxiety' named entity 'Bone Marrow transplantation' named entity 'cancer treatment' named entity 'patient care' named entity 'cancer center' named entity 'medical faculty' named entity 'quarantine' named entity 'aplasia' named entity 'curative intent' named entity 'outpatient' named entity 'rki' named entity 'cancer care' named entity 'oncology' named entity 'SARS-CoV-2' named entity 'cytokine storm' named entity 'Cancer Care' named entity 'health authority' named entity 'patient care' named entity 'SARS-CoV-2' named entity 'interdisciplinary' named entity 'bone pain' named entity 'good clinical practice' named entity 'oncology'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software